{"title":"甲状腺分裂的水母癌。最佳治疗方法","authors":"И. С. Романов, Е. Л. Дронова, Е. Е. Станякина","doi":"10.17650/2222-1468-2018-8-4-21-25","DOIUrl":null,"url":null,"abstract":"Medullary thyroid cancer is a rare tumor. Due to variability of its biological behavior, treatment of this tumor often is a complicated problem. Clinicians have difficulties with determination of indications for prescription of tyrosine kinase inhibitors. Prescription should be based on scru-tinous monitoring of the patients and consideration of all factors: level of tumor markers, patient’s state, and data form visual examinations.","PeriodicalId":36598,"journal":{"name":"Opuholi Golovy i Sei","volume":"8 1","pages":"21-25"},"PeriodicalIF":0.0000,"publicationDate":"2019-01-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Диссеминированный медуллярный рак щитовидной железы. Оптимальный подход к лечению\",\"authors\":\"И. С. Романов, Е. Л. Дронова, Е. Е. Станякина\",\"doi\":\"10.17650/2222-1468-2018-8-4-21-25\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Medullary thyroid cancer is a rare tumor. Due to variability of its biological behavior, treatment of this tumor often is a complicated problem. Clinicians have difficulties with determination of indications for prescription of tyrosine kinase inhibitors. Prescription should be based on scru-tinous monitoring of the patients and consideration of all factors: level of tumor markers, patient’s state, and data form visual examinations.\",\"PeriodicalId\":36598,\"journal\":{\"name\":\"Opuholi Golovy i Sei\",\"volume\":\"8 1\",\"pages\":\"21-25\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-01-12\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Opuholi Golovy i Sei\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.17650/2222-1468-2018-8-4-21-25\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Opuholi Golovy i Sei","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.17650/2222-1468-2018-8-4-21-25","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
Диссеминированный медуллярный рак щитовидной железы. Оптимальный подход к лечению
Medullary thyroid cancer is a rare tumor. Due to variability of its biological behavior, treatment of this tumor often is a complicated problem. Clinicians have difficulties with determination of indications for prescription of tyrosine kinase inhibitors. Prescription should be based on scru-tinous monitoring of the patients and consideration of all factors: level of tumor markers, patient’s state, and data form visual examinations.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
